Azacitidine (AZA) Days 1 - 5
Sponsors
M.D. Anderson Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONLeukemiaRelapseT-cell Acute Lymphoblastic Leukemia
Phase 2
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
CompletedNCT02269280
Start: 2014-10-13End: 2024-07-25Updated: 2025-08-07
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
RecruitingNCT06686108
Start: 2024-10-30End: 2028-10-30Target: 59Updated: 2025-05-07